Hepatitis C virus (HCV) is the major etiologic agent of posttransfusion and sporadic non-A, non-B hepatitis (8, 30) . Chronic infection with HCV has also been linked to the development of liver cirrhosis and of hepatocellular carcinoma (7) . Although the number of new infections has been significantly reduced by the introduction of reliable blood tests, it has been estimated that about 1% of the world population is affected by the disease (1) . So far, no efficient therapy and no vaccine exist.
HCV is related to flavivirus and pestivirus, with which it shares both sequence similarities and homologies in genome organization and in the hydropathy profiles of its gene products. The HCV genome consists of a positive-stranded RNA of 9.5 kb with a single open reading frame encoding a polyprotein of 3,010 to 3,033 amino acids (9, 19, 27, 46) . This polyprotein is proteolytically processed co-or posttranslationally into at least nine different polypeptides which are encoded on the viral RNA as follows: 5Ј-C-E1-E2-NS2-NS3-NS4A-NS4B-NS5A-NS5B-3Ј. Both viral and host-encoded proteases are involved in the production of mature polypeptide chains (4, 13, 17, 18, 21-23, 28, 39, 47) .
The N-terminal third of the NS3 protein encodes a trypsinlike serine protease that performs all cleavages downstream of NS3, i.e., at the NS3-NS4A, NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B junctions (4, 13, 18, 23, 28, 47) . Considerable effort has been devoted to the characterization of its enzymatic activity by using transfection and in vitro translation systems, since this protein appears to be an attractive target for the development of anti-HCV drugs.
Several studies have shown that there is a temporal hierarchy in NS3-mediated polyprotein processing events (5, 15, 23) . In fact, the intramolecular cleavage between NS3 and NS4A has been established to be the first event in the processing cascade, followed by intermolecular cleavage at the NS5A-NS5B and NS4A-NS4B sites. The NS4B-NS5A junction is processed with the lowest efficiency. Moreover, its cleavage is observed only in the presence of the NS4A protein. This 54-residue protein has been demonstrated to bind to the N terminus of NS3 via a central hydrophobic region, thereby enhancing the proteolytic activity of NS3 on all cleavage sites (14, 15, 33, 41) . It has recently been shown that all of the effects of NS4A can be efficiently mimicked by peptides encompassing residues 21 to 34 of the central region of NS4A (34, 42, 44) . Homology modelling of the active site of the NS3 protease has predicted the preference for a cysteine residue at the P1 position of the substrates. Radiosequencing of the single cleavage products has subsequently confirmed these predictions, yielding the consensus sequence D/E-X-X-X-X-C-A/S for all trans-cleavage sites, with X being any amino acid and the scissile bond being located between C and A or S (18, 37) . The intramolecular cleavage site between NS3 and NS4A was found to differ from this consensus, having a T in the P1 position.
Our present interest is focused on gaining a deeper insight into both the mechanism of activation of NS3 by NS4A and the structural determinants of substrate specificity of the protease. For these studies, sufficient amounts of pure, active protease are needed. The NS3 protein is a multidomain protein of 70 kDa with the protease domain at the N terminus and a putative RNA helicase at the C terminus. Several groups have recently reported the expression of enzymatically active NS3 protease, encompassing either both domains or only the protease domain, in bacterial or eukaryotic expression systems (12, 18, 24, 26, 28, 35, 42, 43, 45) . In some cases, fusion proteins have been purified and shown to retain enzymatic activity that was limited to in vitro-translated protein substrates (12, 43, 45) or to a synthetic peptide substrate based on the NS5A-NS5B cleavage site (26, 42) .
We have also recently shown that the NS3 protease domain can be expressed and purified in an active form, using a recombinant baculovirus expression system (44) . In this system, we did not rely on fusion proteins. However, the yield of the procedure turned out to be rather modest.
We now report the expression and purification of large quantities of the NS3 protease domain from Escherichia coli and the characterization of its activity. The purified protein was active on peptide substrates corresponding to the sequences of all trans-cleavage sites. Both the catalytic efficiency of the protease on these peptides and its enhancement by a peptide encompassing NS4A sequences followed the same hierarchy as observed for the polyprotein processing in vivo, indicating that the sequence of a given cleavage site harbors a major determinant of cleavage specificity. We thus demonstrate that the purified enzyme is suitable for enzymological studies as well as for the development of protease inhibitors with therapeutic potential.
MATERIALS AND METHODS
Expression and purification of the protease domain. A DNA fragment encoding amino acid residues 1027 to 1206 of the BK strain HCV polyprotein was cloned downstream of the T7 promoter in the pT7-7 vector, in frame with the first ATG of the protein of gene 10 of the T7 phage, resulting in pT7-7 (NS3 ). This plasmid was used to transform E. coli BL21(DE53). Overnight cultures of transformed cells were diluted 1:1,000 in 5 to 20 liters of standard LB medium containing 100 g of ampicillin per ml and grown at 37ЊC to an optical density of 0.6 to 0.8 at 600 nm. The temperature was lowered to 30ЊC in 15 to 20 min, and 400 M isopropyl-␤-D(Ϫ)-thiogalactopyranoside (IPTG) was added. The temperature was then lowered to 22ЊC within 20 to 30 min, and cells were grown at 22ЊC for a further 3 h, collected by centrifugation, washed with phosphate-buffered saline (20 mM sodium phosphate [pH 7.5], 140 mM NaCl), resuspended in 25 mM sodium phosphate (pH 6.5-0.5% 3-(3-cholamidopropyl)dimethylammonio-1-propanesulfonate (CHAPS)-50% glycerol, 10 mM dithiothreitol (DTT)-1 mM EDTA (10 ml for each liter of original cell suspension), and disrupted with a standard French press. Homogenates were clarified by centrifugation at 120,000 ϫ g for 1 h, and supernatants were batch adsorbed on an SP-Sepharose resin (Pharmacia), equilibrated with 25 mM sodium phosphate (pH 6.5)-10% glycerol-0.5% CHAPS-3 mM DTT (buffer A), under mild stirring for 1 h at 4ЊC; 10 ml of resin suspended in 5 ml of buffer A was used for each liter of original cell suspension. The resin was subsequently poured into an appropriate chromatography column and extensively washed with buffer A, and the protease was eluted by applying a 0 to 1 M NaCl gradient in buffer A. The presence of the NS3 protease in chromatography fractions was detected on Coomassie blue-stained precast sodium dodecyl sulfate (SDS)-12.5% polyacrylamide gels (Phastsystem; Pharmacia) or on Western blots (immunoblots), using polyclonal antibodies (47) . NS3-containing fractions were pooled and concentrated to a protein concentration of 6 to 10 mg/ml (determined with the Bio-Rad protein assay), using an Amicon stirred ultrafiltration cell equipped with a YM-10 membrane. The sample was then loaded on a HR 60/600 Superdex 75 column (Pharmacia) equilibrated with buffer B (50 mM sodium phosphate [pH 7.5], 10% glycerol, 0.5% CHAPS, 3 mM DTT) and operating at 5 ml/min. NS3-containing fractions were pooled and further purified on a HR 5/5 Mono S column (Pharmacia) equilibrated with buffer B and operating at a flow rate of 1 ml/min. The protease was eluted in a pure form from this column by applying a linear 0 to 0.5 M NaCl gradient in buffer B. The protein was stored in aliquots at a concentration of 10 to 30 M in 25 mM sodium phosphate (pH 7.5)-50% glycerol-0.5% CHAPS-30 mM DTT at Ϫ80ЊC after shock-freezing in liquid nitrogen. Protein concentration was estimated by quantitative amino acid analysis or by determination of the A 280 , using an extinction coefficient of 18,200 M Ϫ1 cm
Ϫ1
, derived from primary sequence data. The methods yielded the same results within Ϯ10%. Purity of the enzyme was checked on silver-stained polyacrylamide gels run under denaturing conditions (31) and by high-performance liquid chromatography (HPLC) using a reversed-phase Vydac C 4 column (4.6 by 250 mm, 5 m, 300 Å [1 Å ϭ 0.1 nm]). Eluents were H 2 O-0.1% trifluoroacetic acid (TFA) and acetonitrile-0.1% TFA. A linear gradient from 3 to 95% acetonitrile-0.1% TFA in 60 min was used. N-terminal analysis was carried out by using Edman degradation on an Applied Biosystems model 470A gas-phase sequencer.
Peptides and HPLC assays. Peptide synthesis was performed on a NovaSyn
Gem flow synthesizer by 9-fluorenylmethyloxycarbonyl (Fmoc)-tert-butyl (t-Bu) chemistry (3) . Protecting groups were as follows: N alfa (Fmoc), Asp(Ot-Bu), Glu(Ot-Bu), Tyr(t-Bu), Ser(t-Bu), Thr(t-Boc), His(triphenylmethyl [Trt]), Cys-(Trt), Gln(Trt), Trp(t-Bu). All amino acids were activated by benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate, N-hydroxybenzotriazole, and diisopropylethylamine. Pep A was synthesized with the Fmoc group at the N terminus, while all the other peptides were acetylated by acetic anhydride after final Fmoc deprotection by 20% piperidine solution in dimethyl formamide. All peptides were assembled on a Novasyn PR 500 resin, yielding peptide amides upon cleavage with 88% TFA-5% phenol-2% triisopropylsilane-5% water.
Crude peptides were purified by reversed-phase HPLC on a Nucleosyl C 18 column (250 by 21 mm, 100 Å, 7 m), using H 2 O-0.1% TFA and acetonitrile-0.1% TFA as eluents. Analytical HPLC was performed on a Ultrasphere C 18 column (250 by 4.6 mm, 80 Å, 5 m; Beckman). Purified peptides were characterized by mass spectrometry and amino acid analysis.
Concentration of stock solutions of peptides, prepared in dimethyl sulfoxide (DMSO) and kept at Ϫ80ЊC until use, was determined by quantitative amino acid analysis performed on HCl-hydrolyzed samples.
Cleavage assays were performed in 27 l of buffer solution, to which 3 l of substrate peptide in DMSO, leading to a final DMSO concentration of 10%, was added. Enzyme concentrations (100 nM to 2 M) and incubation times were chosen in order to obtain Ͻ20% substrate conversion. Reactions were stopped by addition of 70 l of 0.1% TFA. Buffer composition was varied in order to optimize assay conditions (see Results). Subsequently, assays were performed under the following standard conditions: 50 mM Tris (pH 7.5), 2% CHAPS, 50% glycerol, and 10 mM DTT. pH dependence experiments were carried out with the following buffers: pH 6.0 to pH 7.5, sodium phosphate; pH 7.5 to pH 9.0, Tris; and pH 9.0 to pH 10.5, sodium borate. At overlapping pH values, activity was determined with two different buffer systems and shown not to be affected by buffer composition. Ionic strength was kept constant at 25 mM.
Cleavage of peptide substrates was determined by HPLC using a MerckHitachi chromatograph equipped with an autosampler. Samples of 90 l were injected on a Lichrospher C 18 reversed-phase cartridge column (4 by 125 mm, 5 m; Merck), and fragments were separated by using a 3 to 100% acetonitrile gradient at 2%/min. Peak detection was accomplished by monitoring both the A 220 nm and fluorescence ( ex ϭ 260 nm, em ϭ 305 nm).
Cleavage products were quantified by integration of chromatograms with respect to appropriate standard peptides or with respect to samples with 100% conversion. Initial rates of cleavage were determined on samples having Ͻ20% substrate conversion. Kinetic parameters were calculated from least-squares fit of initial rates as a function of substrate concentration with the help of Kaleidagraph software, assuming Michaelis-Menten kinetics. k cat /K m values were calculated from the slope of the linear part of the Michaelis-Menten plot at substrate concentrations less than K m .
RESULTS

Expression and purification.
For the expression of the NS3 protease domain in E. coli, we chose a T7-RNA polymerasebased expression system. The protease expressed in this system was quantitatively found in an insoluble form that could easily be resolubilized in either 8 M urea or 6 M guanidine hydrochloride in the presence of DTT. However, refolding trials using resolubilized material eventually failed. We therefore tried to push the system toward expression of a soluble protein.
To this purpose, cells were grown at 37ЊC to the desired optical density, after which the temperature was lowered to 30ЊC. Induction of NS3 protease synthesis was obtained by addition of 400 M IPTG, and cells were grown for further 3 h at 22ЊC. About 70% of the induced protease was recovered in a soluble form upon disruption of cells in a glycerol-and CHAPScontaining buffer (see Materials and Methods for details). The protease was then purified by batch adsorption on SPSepharose, gel filtration, and ion-exchange chromatography on Mono S (Fig. 1) . The purified enzyme was homogeneous, as judged by SDS-polyacrylamide gel electrophoresis (PAGE) (Fig. 1) and HPLC (not shown). M-A-P-I-T-A-Y-S-S-Q was the expected N-terminal amino acid sequence, as deduced from DNA sequence data. However, experimental sequence analysis revealed the removal of the N-terminal methionine and alanine residues, yielding the sequence P-I-T-A-Y-S-S-Q. Electrospray mass spectrometry gave a molecular weight of 18,806.8 Ϯ 0.8 for the purified enzyme, which is compatible with a protein encompassing residues Pro-1028 to Arg-1206 of the HCV polyprotein, thereby indicating a uniform C termi- VOL. 70, 1996 HCV PROTEASE 6695
nus. The yield of the purification procedure was 2 mg of purified protein per liter of bacteria. Characterization of enzymatic activity. To determine whether the purified protein was enzymatically active, aliquots were incubated with the 20-mer peptide Fmoc-
, corresponding to the NS4A-NS4B cleavage site. The presence of the Fmoc group at the N terminus of the peptide permitted fluorescence monitoring. Subsequent HPLC analysis revealed the appearance of two novel UV-detectable peaks and one novel fluorescent peak that were absent in samples not containing the protease (not shown). When injected as a standard, the peptide A-S-H-L-P-Y-I-E-Q-G, which corresponds to the putative C-terminal proteolysis product, cochromatographed with one of the cleavage products. As a further proof, the latter product was isolated by HPLC and analyzed by mass spectrometry, yielding the expected molecular weight of 1,114.0. These findings demonstrate that cleavage occurred as expected between the cysteine and alanine residues of the peptide. We also found that a shorter peptide having the sequence Ac-D-E-M-E-E-C-A-S-H-L-P-Y-K (Pep B) was cleaved by the protease with an efficiency comparable to that observed with the 20-mer peptide (see below). Using this latter peptide, we investigated the effect of activation of the protease by NS4A. For this purpose, we used a 14-mer peptide corresponding to the central hydrophobic core spanning residues 21 to 34 of the NS4A protein, Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Figure 2 shows a Pep4A 21-34 activity titration experiment, indicating that the maximum degree of activation induced by the peptide was about sixfold. Moreover, this maximum activation was obtained at Ն1 M peptide and 1 M enzyme, indicating a 1:1 stoichiometry of the protease-Pep4A 21-34 complex.
We used the ability of the purified protease to cleave peptides based on the sequence of the NS4A-NS4B junction to optimize assay conditions. Since it had emerged from the purification experiments that optimal solubilization was obtained only in the presence of detergents and glycerol, we checked the effects of different zwitterionic and nonionic detergents on the enzymatic activity. The detergent CHAPS proved to both solubilize and to activate the protease in an optimal fashion. We checked the effect of varying the glycerol concentration at a fixed amount (2%) of CHAPS on the activity of the purified NS3 protease (Fig. 3A) . This titration experiment indicated that optimal activities were obtained between 30 and 50% glycerol, both in the presence and in the absence of saturating amounts of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . When CHAPS was omitted from the buffer, no activity could be detected at any tested glycerol concentration in the absence of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] (Fig. 3B) . In the presence of the cofactor, however, a glycerol-dependent activity increase was observed. Again, a plateau value was reached at 40 to 50% glycerol. We subsequently maintained the glycerol concentration constant at 50% and performed a CHAPS titration experiment (Fig. 3C) . In the absence of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , the protease activity was strictly dependent on the presence of CHAPS, reaching a plateau value at CHAPS concentrations above 1.5%. In the presence of the cofactor, the activity was only marginally affected by the CHAPS (Fig. 3C) . On the basis of these findings, we defined 50% glycerol and 2% CHAPS as optimum conditions.
As a next step, we determined the pH dependence of the cleavage reaction of Pep B at the previously defined glycerol and CHAPS concentrations. The pH optimum of catalysis was between pH 8.0 and 8.5 (not shown).
In the presence of 10% DMSO, used as the solvent for the peptide substrate, the enzyme was sufficiently stable at pH 7.5 (about 10% activity decrease after 3 h of incubation at 22ЊC). However, stability decreased with increasing pH: at pH 8.5, about 25% inactivation was observed during the same incubation time. In the absence of DMSO, the enzyme underwent a much slower, temperature-dependent inactivation, with halftimes of about 10, 30, and 60 h at 30, 23, and 15ЊC, respectively. Instability was unlikely to be related to autoproteolysis phenomena, since samples at a concentration of 10 M could be kept at 23ЊC for 5 days without yielding degradation products detectable either by SDS-PAGE or by reversed-phase HPLC (not shown). It is possible that protein denaturation or thiol oxidation is implicated in the process of inactivation. The latter hypothesis is favored by the fact that the protease contains seven cysteine residues and was readily inactivated by the thiolmodifying agent N-ethylmaleimide (not shown). Furthermore, a pronounced enzyme inactivation was also noticed at DTT concentrations below 1 mM (not shown).
NaCl titration experiments (Fig. 4A ) indicated that the protease was susceptible to inhibition by increased ionic strength, with a considerable drop in activity detectable at 50 mM NaCl. This susceptibility was significantly decreased in the NS3-Pep4A 21-34 complex (Fig. 4A) . Kinetic analysis of the data revealed that NaCl behaved as a competitive inhibitor up to a concentration of 100 mM (Fig. 4B) . Above this concentration, effects on k cat became also evident, possibly indicating the occurrence of ionic strength-dependent structural alterations.
We performed a kinetic analysis of the cleavage reaction of Pep A and Pep B under our optimized conditions, i.e., in 50 mM Tris (pH 7.5)-50% glycerol-2% CHAPS-10 mM DTT with incubation time up to 3 h at 23ЊC, and obtained the . Activity on C-and N-terminally truncated substrate peptides. Our next interest was focused on analyzing the activity of the NS3 protease on peptide substrates corresponding to the other two trans-cleavage sites and on investigating the relative effects of NS4A on the cleavage kinetics. To address these issues, we first determined the minimum substrate length by performing truncation experiments on NS4A-NS4B cleavage site-derived peptides, starting with the 20-mer peptide Pep A (Table 1) . C-terminal truncations from P10Ј to P1Ј caused a steady decrease in catalytic efficiency expressed as k cat /K m . This decrease was attributable to both an increase of the respective K m values, indicating a weaker binding of the truncated peptides to the enzyme, and a decrease of k cat . It has to be pointed out that activities on peptides having deletions beyond P4Ј were very difficult to detect by HPLC because of comigration of the substrate and the N-terminal cleavage product. The P4Ј residue was therefore defined as the C-terminal boundary. N-terminal truncations affecting the P6 residue caused a more than 10-fold decrease in k cat /K m . Thus, our data define a decamer peptide spanning from P6 to P4Ј as a minimum substrate on which activity can be reasonably well detected by a standard HPLC method. Activity on decamer peptides corresponding to all transcleavage sites. On the basis of the foregoing findings, we synthesized P6-P4Ј decapeptides corresponding to all trans-cleavage sites and compared their cleavage rates. Kinetic data were determined in the absence and in the presence of saturating amounts of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Table 2 summarizes the results. Cleavage efficiency, expressed as k cat /K m , was best for the NS5A-NS5B-derived peptide, followed by the NS4A-NS4B-derived peptide, whereas the NS4B-NS5A-derived peptide was cleaved with a 250-fold-lower efficiency. This low efficiency was due both to weak binding of the peptide to the protease (high K m value) and to a low turnover (low k cat value). For this substrate, also the largest activating effect of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] (100-fold) was observed, while the smallest enhancement in k cat /K m (3-fold) was determined for the NS5A-NS5B decamer. An intermediate (11-fold) effect was measured for the NS4A-NS4B peptide. In the case of the two latter peptides, the cleavage enhancement produced by Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] was mainly attributable to an improved substrate turnover, as reflected by an increase in k cat . In the case of the NS4B-NS5A decamer substrate, peptide Pep4A 21-34 acted by both increasing k cat (16.5-fold) and decreasing K m (6.5-fold).
DISCUSSION
We describe here the production of the HCV NS3 protease domain in E. coli and the characterization of its enzymatic activity.
The synthesis of soluble protein was crucially temperature dependent, induction above 30ЊC leading quantitatively to aggregates that failed to refold productively upon solubilization in urea or guanidine. Protein induction at 22ЊC, followed by batch adsorption to an ion exchanger as a first purification step that permitted routine handling of 5 to 20 liters of E. coli cultures, led to several milligrams of purified protein within a few days.
We attempted to define the conditions necessary for the reproduction of the enzymatic activity of purified NS3. For this purpose, we chose peptides based on the sequence of the NS4A-NS4B junction.
High glycerol and detergent concentrations were required for optimal activity. Provided that the protein concentration was kept in the low-micromolar range, the effects of glycerol and detergent were fully reversible. Thus, preincubation under conditions of low CHAPS and glycerol followed by activity measurement under optimum conditions did not affect the specific activity of the protease (43a). In the light of these results, the activity-enhancing effect of both agents is suggestive of a reversible stabilization of an active conformation. In addition, hydrophobic conditions could favor enzyme-substrate complex formation by strengthening crucial electrostatic interactions. In fact, the interaction of the protease with NS4A-NS4B-based substrates appears to be dominated by electrostatic effects, as shown by the competitive inhibition caused by NaCl (see below).
Activation by kosmotropic agents such as glycerol has been described for other viral proteases such as herpes simplex virus protease and cytomegalovirus protease (20, 36, 49) . In these cases, a correlation between activity enhancement and changes in protein conformation could be shown by fluorescence spectroscopy and limited proteolysis (20, 36) .
In this context, it is interesting that the physicochemical requirements for optimal activity of the NS3 protease changed significantly upon complex formation with the cofactor peptide Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . In fact, the activity of the NS3-Pep4A 21-34 complex was still glycerol dependent but became much less dependent on the presence of detergent. Furthermore, a substantial change in the shape of the ionic strength dependence curve of the activity was noticed. Altogether, these data may be interpreted in terms of some conformational rearrangements occurring upon binding of the cofactor to the protease domain, resulting in altered requirements for kosmotropic cosolvents such as glycerol and detergents.
The proteolytic activity of NS3 was rather low (k cat /K m ϭ 0.4 to 650 M Ϫ1 s
Ϫ1
, depending on the substrate and on the presence of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ) but in the same order of magnitude of that found for other viral proteases (10, 11, 40) . Furthermore, our data are in line with recent a report about the purification of a protein encompassing the full-length NS3 fused to maltosebinding protein (42) . From activity data obtained with this protein, using a peptide substrate derived from the NS5A-NS5B junction, k cat /K m between 5 and 250 M Ϫ1 s Ϫ1 was calculated, depending on the presence of the cofactor peptide.
Having defined conditions suitable for the detection of enzymatic activity of the NS3 protease, we started to investigate its activity on different peptide substrates. N-terminal deletions showed that activity was gradually reduced by deleting residues P10 to P7, whereas a sharp drop in activity was observed upon truncation of the P6 residue. Indeed, a negatively charged residue in this position is conserved in all cleavage sites. The competitive inhibition of the enzyme caused by NaCl could be due to interference of chloride ions with specific contacts of this residue with a putative positively charged S6 pocket.
The truncation studies permitted us to define a peptide spanning from P6 to P4Ј as a suitable substrate and allowed us to address the question of what factors determine the temporal sequence of cleavage events during polyprotein processing. Previous studies (4, 5, 13-15, 18, 23, 28, 33, 41, 47) have established the following order of cleavage events on the junctions processed intermolecularly: NS5A-NS5B Ͼ NS4A-NS4B Ͼ NS4B-NS5A, cleavage at the latter site being dependent on previous complex formation with NS4A. We have shown ( Table 2 ) that this hierarchy of cleavage efficiency can be reproduced by using synthetic decamer peptides. These a Protease activity was measured in 50 mM Tris (pH 7.5)-50% glycerol-10 mM DTT-2% CHAPS after incubation for up to 3 h at 22ЊC in the presence of at least five different peptide concentrations and 0.5 to 1 M protease. Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] was added where indicated at a final concentration of 3 M. Reactions were stopped with 0.1% TFA and products, were analyzed by HPLC. Data are mean values of two different experiments with standard errors Ͻ30%. ND, not determined.
findings indicate that primary structure is an important determinant of cleavage efficiency. According to our data, the NS4B-NS5A site was cleaved with the lowest efficiency as a result of low binding affinity of the enzyme for this particular sequence. In contrast, the NS4A-NS4B-derived peptide was bound with the highest affinity, but k cat of this substrate was about 14-fold lower than the corresponding value of the NS5A-NS5B-derived substrate. Different efficiencies of cleavage could serve as an alternative to regulated expression of proteins in other systems. Such a regulatory mechanism has been proposed for picornaviruses (29) , in which the 3C protease is modulated in its activity by the presence of 3D, the RNAdependent RNA polymerase, within the same precursor: in fact, 3C and 3CD have been shown to have different substrate specificities (25, 50) . In a similar way, precursors, intermediates, and final cleavage products of the nonstructural region of the HCV polyprotein could accomplish different, as yet unrecognized functions in the infected cell.
In this context, the regulation of the protease activity by the NS4A cofactor may serve as a further means to control the ratio between the processing products of the HCV nonstructural proteins. Our kinetic data shed some light on the mechanism by which NS4A activates the protease. Several different mechanisms (12, 14, 15, 33, 39, 41) have been suggested, including stabilization, membrane anchoring, alteration of cleavage site specificity, direct contribution to substrate binding, or induction of structural changes in the substrate binding pocket(s). Our data favor the hypothesis of NS4A altering the efficiency of the interaction with the substrate. Full activation was obtained upon formation of a 1:1 complex between the protease and Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . The main effect of Pep4A 21-34 on the cleavage kinetics of both NS4A-NS4B and NS5A-NS5B-derived peptide substrates was to increase k cat . This increase could be accomplished by affecting transition state binding and/or by increasing the nucleophilicity of the active site serine residue. Still, the effect of NS4A on cleavage sites that are processed also in the absence of the cofactor could differ qualitatively from the effect on the NS4B-NS5A site. As a matter of fact, the large activating effect of Pep4A 21-34 on this substrate was due to both an increase in k cat and an enhancement of the affinity of the enzyme for this site. Although both exact intracellular polyprotein precursor concentrations and the K m values of the junctions in the context of the polyprotein are unknown, one can speculate that the affinity of NS3 for a given site might become crucial for cleavage efficiency at the presumably low substrate concentrations in the infected cell. Thus, the effect of Pep4A [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] to quite selectively decrease the K m value of NS3 for the NS4B-NS5A site might account for the observed absolute cofactor requirement of this site during polyprotein processing.
Modulation of viral protease activity by cofactors has been reported for several other systems. In adenovirus, an 11-mer peptide derived from the structural protein pVI has been shown to form a disulfide-linked heterodimer with the adenovirus type 2 protease, thereby activating it (48) . In flavivirus, the NS3 protease has been shown to form a complex with the NS2B protein, which shares many features with the HCV NS4A cofactor, including similar hydropathy plots (2) .
The quantitative aspects of the activation of the HCV protease by its cofactor deserve some further considerations. Apparently, there are sequence-specific determinants that affect the extent by which the cleavage of a given substrate is enhanced by NS4A. There is an apparent inverse relationship between the basal cleavage rate of a peptide substrate and its activation by NS4A. Thus, cleavage of the NS4B-NS5A-derived peptide was enhanced about 100-fold by NS4A, whereas only a modest 3-fold activation was observed using the NS5A-NS5B-based substrate (Table 2) . Furthermore, there seem to exist also protein-specific factors that influence the degree of activation by NS4A. We have previously reported the purification of the protease domain from a baculovirus expression system (44) . With Pep A as a substrate, this enzyme had a specific activity (k cat /K m ϭ 174 M Ϫ1 s
) that is in good agreement with the specific activity found for the enzyme purified from E. coli (k cat /K m ϭ 143 M Ϫ1 s Ϫ1 ). However, the extent of activation by Pep4A 21-34 on NS4A-NS4B-based substrates was reproducibly lower for the former enzyme (2-to 3-fold, compared with 6-to 10-fold). A possible explanation resides in the differences in the primary structure of the two enzymes. The protease purified from the baculovirus expression system spans residues 1039 to 1226 of the HCV polyprotein, compared with residues 1028 to 1206 of the enzyme purified from the bacterial source. In particular, the differences in the length of the N terminus, a region which has been shown to be important for complex formation (15) , might account for the observed differences in the degree of activation of the cleavage by NS4A. Further enzymological studies are needed to evaluate the kinetic effects of the interaction between the NS3 protease and its cofactor.
The importance for the physiology of viral replication of a hierarchy of cleavage events during polyprotein processing and the role of its regulation by the NS4A cofactor remain intriguing, open questions. In the light of the pivotal role that proteolytic events mediated by the NS3 protease apparently play in the course of the viral life cycle, compounds able to interfere with the activity of this enzyme could be promising candidate drugs. The possibility to produce large amounts of enzymatically active protease and to monitor its activity by using peptidic substrates will be helpful for the development of firstgeneration inhibitors.
